TY - JOUR
T1 - Medical therapy for glaucoma
T2 - What to add after a prostaglandin analogs?
AU - Tanna, Angelo P.
AU - Lin, Albert B.
N1 - Publisher Copyright:
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2015
Y1 - 2015
N2 - For patients already on a PGA, the mean diurnal IOP-lowering achieved with the addition of an alpha2 adrenergic agonist, a beta adrenergic antagonist, or a topical carbonic anhydrase inhibitor is similar, whereas the side-effect profiles, nocturnal IOP-lowering efficacy, and trough IOP-lowering effects vary. Laser trabeculoplasty is also an effective means of further lowering the IOP in patients on a PGA.
AB - For patients already on a PGA, the mean diurnal IOP-lowering achieved with the addition of an alpha2 adrenergic agonist, a beta adrenergic antagonist, or a topical carbonic anhydrase inhibitor is similar, whereas the side-effect profiles, nocturnal IOP-lowering efficacy, and trough IOP-lowering effects vary. Laser trabeculoplasty is also an effective means of further lowering the IOP in patients on a PGA.
KW - Alpha adrenergic agonist
KW - Beta adrenergic antagonist
KW - Carbonic anhydrase inhibitor
KW - Glaucoma
KW - Prostaglandin analog
UR - http://www.scopus.com/inward/record.url?scp=84926209617&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84926209617&partnerID=8YFLogxK
U2 - 10.1097/ICU.0000000000000134
DO - 10.1097/ICU.0000000000000134
M3 - Review article
C2 - 25594765
AN - SCOPUS:84926209617
SN - 1040-8738
VL - 26
SP - 116
EP - 120
JO - Current opinion in ophthalmology
JF - Current opinion in ophthalmology
IS - 2
ER -